[
    "This sample is a phase 3 clinical trial for patients with atrial fibrillation and atrial flutter, testing the effectiveness of dronedarone (sr33589) compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for liver transplantation patients who are receiving immunosuppressive therapy with calcineurin inhibitors and corticosteroids, and the study aims to evaluate the efficacy of sirolimus and cyclosporine or tacrolimus as potential drugs for this population.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of rivastigmine transdermal patches in patients aged 50 and above with a diagnosis of probable Alzheimer's disease and an MMSE score between 10 and 24. The inclusion criteria also require patients to have a caregiver who can attend all study visits and have received continuous treatment with donepezil for at least 6 months prior to screening. The exclusion criteria include various medical conditions and disabilities that may interfere with the study.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of ziprasidone oral capsule and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with congestive heart failure, testing the effectiveness of dronedarone and placebo in reducing symptoms and improving heart function, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with acute myelogenous leukemia (AML) who have relapsed or are refractory to prior chemotherapy regimens. The study aims to evaluate the efficacy and safety of clofarabine, cytarabine, and placebo in this patient population. The inclusion and exclusion criteria outline the eligibility requirements for participants, including age, disease status, prior treatments, and organ function.",
    "This sample is a phase 3 clinical trial for patients with metastatic prostate cancer that is unresponsive to hormone therapy, testing the effectiveness of chemotherapy (docetaxel and prednisone) in reducing cancer-related pain.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of lixisenatide, metformin, and sulfonylurea in controlling blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with ovarian, peritoneal, or fallopian tube cancer who are resistant to platinum and taxane treatment. The study will test the effectiveness of tamoxifen and chemotherapy in patients who have not responded to previous treatments.",
    "This sample is a phase 3 clinical trial for breast cancer patients who have undergone modified radical mastectomy, with specific eligibility criteria, and the study will test the effectiveness of epirubicin, cyclophosphamide, paclitaxel, carboplatin, and g-csf as treatment options.",
    "This phase 3 clinical trial aims to evaluate the efficacy of erlotinib hydrochloride and pemetrexed disodium in treating patients with recurrent non-small cell lung carcinoma, stage IIIB/IIIA/IV non-small cell lung cancer, with specific eligibility criteria including confirmed NSCLC, measurable disease, prior radiation therapy, and various laboratory parameters within normal limits.",
    "This sample is a phase 3 clinical trial for fibromyalgia and neurocognition, testing the effectiveness of milnacipran and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of schizophrenia, with the drugs asenapine, placebo, and olanzapine being tested, and the eligibility criteria including currently suffering from an acute exacerbation of schizophrenia.",
    "This sample is a phase 3 clinical trial for the treatment of acquired immunodeficiency syndrome (AIDS) and HIV infections using the drugs cobi, drv, and nrtis, with specific eligibility criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy of asenapine, a drug used to treat bipolar disorder, in pediatric patients with bipolar I disorder, while considering various inclusion and exclusion criteria for participant selection.",
    "This phase 3 trial is testing the effectiveness of flutiform 250/10, skp-fluticasone, and flovent fluticasone hfa in patients with asthma who are steroid-requiring and have an FEV1 of 40% to 80% of predicted normal values, with documented reversibility.",
    "This sample is a phase 3 clinical trial for patients with uncontrolled hypertension, testing the drug telmisartan/amlodipine, and includes eligibility criteria such as age, blood pressure levels, and exclusion criteria such as pregnancy, secondary hypertension, and renal dysfunction.",
    "This sample is a phase 3 clinical trial for gastroesophageal reflux disease (GERD) using pantoprazole sodium enteric-coated spheroid as the drug, with specific inclusion and exclusion criteria for children aged 1 through 5 years.",
    "This sample is a phase 3 clinical trial for bladder cancer, testing the drugs apaziquone and placebo, with eligibility criteria including having written informed consent, being at least 18 years old, having transitional cell carcinoma of the bladder with clinically apparent tumor Ta, grade G1-G2, and not having certain exclusion criteria such as having more than 5 bladder tumors or a bleeding disorder.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia or psychotic disorders, testing the effectiveness of aripiprazole, risperidone long acting injectable (lai), and quetiapine as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of idrabiotaparinux sodium, warfarin, and placebos in treating symptomatic pulmonary embolism with or without symptomatic deep vein thrombosis, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of olanzapine, risperidone long acting injectable (lai), and placebo in treating bipolar disorder, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with HER2-positive metastatic or unresectable locally advanced/recurrent breast cancer, testing the efficacy of trastuzumab emtansine and treatment of physician's choice as a third-line therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of empagliflozin compared to placebo, with specific inclusion and exclusion criteria related to diabetes diagnosis, antidiabetic drug treatment, and glycemic control.",
    "This sample is a phase 3 clinical trial for idiopathic pulmonary fibrosis (IPF) patients, testing the efficacy of ambrisentan compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of rituximab, fludarabine phosphate, and cyclophosphamide as treatment options, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of obesity in overweight/obese individuals with type 2 diabetes mellitus, using lorcaserin or a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with poorly controlled type 2 diabetes, testing the effectiveness of the drugs ly2189265, exenatide, metformin, and pioglitazone, along with a placebo, in combination with oral antidiabetic medications. The eligibility criteria include specific HbA1c levels, tolerance to metformin and pioglitazone, willingness to inject medication, stable weight, and BMI range. Exclusion criteria include type 1 diabetes, certain medical conditions, and recent participation in other clinical trials.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of golimumab and methotrexate in reducing disease activity, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for prostate cancer patients, testing the drug leuprolide acetate for medical androgen deprivation therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for Huntington disease, testing the drugs acr16 10 mg, acr16 22.5 mg, and acr16 45 mg, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for postmenopausal women with osteoporosis, testing the effectiveness of teriparatide and other drugs in improving bone density, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is investigating the effectiveness of dexlansoprazole mr and lansoprazole in treating patients with esophagitis, reflux and esophagitis, peptic, as confirmed by endoscopy, while excluding patients with certain conditions and medication use.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe chronic low back pain, testing the effectiveness of buprenorphine transdermal system compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the drugs fenofibrate/simvastatin and pravastatin for the treatment of hyperlipidemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the drug adalimumab in patients with psoriatic arthritis who have had an unsatisfactory response or intolerance to at least two prior or ongoing DMARDs, and the eligibility criteria include having active psoriatic arthritis defined by tender or painful joints and swollen joints.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of cariprazine and placebo in treating the disease, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of fibromyalgia using milnacipran hydrochloride, with specific inclusion and exclusion criteria listed.",
    "This sample is a phase 3 clinical trial for patients with osteoarthritis, hip or knee, lower back pain, and pain, testing the effectiveness of oxycodone cr and tapentadol er as analgesic therapy for patients dissatisfied with their current treatment.",
    "This phase 3 trial focuses on patients with chronic obstructive pulmonary disease (COPD) and aims to evaluate the efficacy of formoterol turbuhaler\u00ae 4.5mg, formoterol turbuhaler\u00ae 9 mg, and turbuhaler\u00ae placebo in improving lung function parameters. The study includes specific inclusion and exclusion criteria, such as age, smoking history, lung function parameters, and exclusion of asthma or atopic diseases.",
    "This sample is a phase 3 trial for postmenopausal women with sexual dysfunction, testing the effectiveness of tibolone and estradiol-norethisterone in improving sexual activity and satisfaction, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for advanced non-small-cell lung cancer, testing the drugs pf-3512676 + paclitaxel + carboplatin and paclitaxel + carboplatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of restless legs syndrome, testing the drugs xp13512 600mg, xp13512 1200mg, and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for macular edema associated with diabetes mellitus, testing the drugs \"standard of care\" and \"macugen\" on patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drug nifedipine (adalat, baya1040), and the inclusion criteria include patients who completed a previous 8-week double-blind treatment phase.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic prostate cancer, testing the drug triptorelin (decapeptyl\u00ae) for 8 months followed by an 8-month treatment extension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for thromboembolism, testing the effectiveness of certoparin and unfractionated heparin in hospitalized medical patients aged 70 or older with acute medical illness and decreased mobility. The inclusion criteria include written informed consent, while the exclusion criteria include prior major surgery, trauma, or invasive procedures, immobilization longer than 3 days, and indication for anticoagulatory or thrombolytic therapy.",
    "This sample is a phase 3 clinical trial for patients with relapsing-remitting multiple sclerosis, testing the effectiveness of fingolimod 1.25 mg, fingolimod 0.5 mg, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of pharyngitis using the drug celecoxib, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to evaluate the effectiveness of oxycodone/naloxone controlled-release and placebo in reducing moderate to severe chronic low back pain in subjects who have been on stable opioid analgesic therapy for at least 4 weeks, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with plaque-type psoriasis, testing the effectiveness of secukinumab 150mg and secukinumab 10mg/kg i.v. regimen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with psoriatic arthritis, testing the effectiveness of infliximab + methotrexate and methotrexate alone as treatment options, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for asthma, testing the drug budesonide/formoterol, and includes eligibility criteria such as age range and exclusion criteria related to hospital admission and corticosteroid dosage.",
    "This phase 3 clinical trial is testing the effectiveness of ciclesonide, placebo, and salbutamol in treating asthma patients who have a history of asthma for at least 6 months and can demonstrate optimal use of MDI inhalation technique, with specific lung function and reversibility limits.",
    "This sample is a phase 3 trial for restless legs syndrome, testing the drugs gen (xp13512) and placebo, with inclusion criteria based on the International RLS Study Group Diagnostic Criteria and exclusion criteria including sleep disorders, neurologic diseases, abnormal laboratory results, pregnancy, and inadequate birth control.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis in children aged 6 to <15 years, using fluticasone furoate and placebo as drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the efficacy of tiotropium high dose and tiotropium low dose compared to placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial testing the effectiveness of mk0653a, ezetimibe (+) simvastatin and atorvastatin in treating cardiovascular diseases and diabetes mellitus, with specific eligibility criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of various drugs, including arformoterol tartrate inhalation solution and formoterol, in treating chronic obstructive pulmonary disease (COPD) in subjects with a history of smoking, while excluding those with asthma or other active pulmonary conditions.",
    "This sample is a phase 3 clinical trial for renal transplantation, testing the drugs cyclosporin a, belatacept less intensive regimen (li), and belatacept more intensive regimen (mi), with specific inclusion and exclusion criteria for the subjects.",
    "This sample is a phase 3 clinical trial for patients with HIV-associated distal symmetrical polyneuropathy, testing the effectiveness of capsaicin dermal patch in reducing pain symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for sickle cell disease and sickle cell anemia, testing the drug ICA-17043, with inclusion criteria including completion of a previous study, stable dose of HU, and written informed consent.",
    "This sample is a phase 3 trial for the treatment of phenylketonuria (PKU) using sapropterin dihydrochloride, with inclusion criteria including age, confirmed diagnosis of PKU, and willingness to continue current diet, and exclusion criteria including hypersensitivity to sapropterin dihydrochloride, recent use of investigational products, and concurrent diseases or conditions that would interfere with study participation.",
    "This sample is a phase 3 clinical trial for patients with lymphoma, testing the effectiveness of the CHOP regimen (including drugs such as carmustine, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, and vincristine sulfate) in combination with other eligibility criteria such as disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This phase 3 clinical trial is investigating the effectiveness of escitalopram oxalate and placebo in patients with various advanced stage cancers, including lung, pancreatic, liver, gallbladder, bile duct, esophageal, gastric, and colorectal cancer, as well as major depressive disorder. Eligibility criteria include specific disease diagnoses, duration of depressive symptoms, and certain patient characteristics.",
    "This phase 3 trial aims to evaluate the effectiveness of ramelteon, a drug used for insomnia, compared to a placebo in patients with bipolar disorder and sleep disturbances, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 2/phase 3 trial for the treatment of impetigo, a skin infection, using experimental and placebo comparator drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of bipolar disorder and depression using lamotrigine regular and novel formulations, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin and pioglitazone combination therapy compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of benign prostatic hypertrophy (BPH) using the drugs ozarelix/placebo. The eligibility criteria include age, clinical signs and symptoms of BPH, IPSS score, peak urinary flow rate, and agreement not to use other BPH treatments. Exclusion criteria include a history of prostate cancer, prior surgeries or radiation, and certain bladder volume and residual urine volume measurements.",
    "This sample is a phase 3 clinical trial for patients with poorly controlled type 2 diabetes, testing the effectiveness of insulin glargine, ly2189265, metformin, and glimepiride in improving glycemic control. The inclusion criteria include specific HbA1c levels and willingness to inject medication, while the exclusion criteria include type 1 diabetes, certain medical conditions, and recent participation in other clinical trials.",
    "This sample is a phase 3 clinical trial for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) using immune globulin IV and albumin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with clear cell renal cell carcinoma (RCC) who have received prior systemic treatment. The study aims to evaluate the efficacy and safety of pazopanib compared to placebo as a second-line treatment option. The eligibility criteria include specific requirements for disease diagnosis, measurable lesions, prior treatments, organ function, and exclusion of certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia, testing the effectiveness of bendamustine at different doses, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for chronic pain, testing the effectiveness of oros hydromorphone and placebo in patients with osteoarthritis pain of the hip or knee who require daily opioid medication, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for depression and cognition, testing the effectiveness of duloxetine and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with non-muscle invasive bladder cancer, testing the drugs epirubicin hydrochloride and mitomycin c, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This sample is a phase 3 clinical trial for post-traumatic stress disorder (PTSD) patients, testing the effectiveness of quetiapine fumarate and its placebo in reducing symptoms. The eligibility criteria include having PTSD symptoms for at least 12 months, while exclusion criteria include a history of psychotic conditions and previous unsuccessful use of quetiapine or other antipsychotics.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the effectiveness of nifedipine (adalat, baya1040) in combination with other antihypertensive drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of mometasone furoate and placebo in treating seasonal allergic rhinitis, with inclusion criteria including a documented history of SAR, positive skin-prick test response, and being clinically symptomatic, while exclusion criteria include allergies to medications, chronic sinusitis, and dependence on certain nasal medications.",
    "This sample is a phase 3 trial investigating the use of dabigatran and warfarin in patients with thromboembolism, with specific inclusion and exclusion criteria related to the disease and treatment.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, male erectile disorder, stage I and II prostate cancer. The trial will test the effectiveness of sildenafil citrate and alprostadil in patients undergoing BNS-RAP for prostate cancer who are able to achieve erections sufficient for intercourse prior to surgery. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for patients diagnosed with bronchial asthma, testing the effectiveness of budesonide and fluticasone, two inhaled steroids, in controlling poorly controlled asthma symptoms.",
    "The sample is a phase 3 trial for the treatment of lipid metabolism disorders, including hypercholesterolemia, using the drug mipomersen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with advanced prostate cancer, testing the effectiveness of docetaxel and prednisone as treatment options, with specific eligibility criteria including disease progression and previous treatments.",
    "This phase 3 trial is testing the effectiveness of doxorubicin, cyclophosphamide, and docetaxel in treating large resectable or locally advanced breast cancer in women aged 18-70, with specific eligibility criteria including measurable disease, no prior surgery or chemotherapy, and adequate bone marrow, liver, and renal function.",
    "This sample is a phase 3 trial for patients with bipolar disorder, focusing on those who are currently depressed. The study will test the effectiveness of quetiapine fumarate (Seroquel\u2122), a mood stabilizer, in treating the symptoms.",
    "This sample is a phase 3 clinical trial for patients with renal cell carcinoma (RCC) who have experienced disease progression while on first-line sunitinib therapy. The trial will evaluate the efficacy of sorafenib and temsirolimus in treating RCC. The eligibility criteria include confirmed diagnosis of metastatic RCC, at least 2 weeks since prior treatment, and at least 1 measurable lesion per RECIST criteria. Exclusion criteria include metastatic CNS from RCC, intolerance to Sutent therapy, prior systemic therapy for mRCC other than sunitinib, and active ketonuria due to poorly controlled diabetes mellitus.",
    "This phase 3 clinical trial is investigating the effectiveness of cisplatin and gemcitabine hydrochloride in treating patients with unresectable locally advanced, recurrent, or metastatic extrahepatic bile duct cancer or gallbladder cancer, and it includes eligibility criteria such as performance status, hematopoietic and hepatic function, renal function, and prior concurrent therapy.",
    "This sample is a phase 3 trial for the treatment of schizophrenia and schizoaffective disorder using lurasidone hcl, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drugs aprepitant and placebo, and enrolling patients who have been diagnosed with Major Depressive Disorder.",
    "This sample is a phase 3 clinical trial for patients with gastrointestinal stromal tumor, testing the effectiveness of imatinib mesylate as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for heart failure patients with specific inclusion and exclusion criteria, testing the drugs rolofylline and placebo, and requiring certain symptoms and blood pressure levels for eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of untreated metastatic colorectal carcinoma, using drugs such as bevacizumab, erlotinib, and low dose capecitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for osteoporosis, testing the drugs odanacatib, placebo, vitamin d3, and calcium supplement, with inclusion criteria including postmenopausal status and specific bone density requirements, and exclusion criteria including previous hip fracture and prior treatment with certain bone-affecting agents.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the drug zoledronic acid, and includes eligibility criteria such as age and exclusion criteria such as current use of bisphosphonates and history of severe liver, kidney, or eye disease.",
    "This sample is a phase 3 clinical trial for participants with idiopathic Parkinson's disease, testing the efficacy of preladenant and placebo drugs in reducing motor fluctuations and dyskinesias, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic pain, evaluating the efficacy of fentanyl buccal tablets in managing breakthrough pain episodes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic renal failure requiring hemodialysis, testing the effectiveness of soluble ferric pyrophosphate (sfp) in maintaining hemoglobin levels within a specific range, with various inclusion and exclusion criteria for each stage of the trial.",
    "This sample is a phase 3 trial for the drug vildagliptin and placebo in patients with type 2 diabetes, with specific inclusion and exclusion criteria, and the primary disease being studied is diabetes mellitus, type 2.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of the drug combination of teneligliptin and pioglitazone compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic hepatitis B, testing the drug telbivudine (ldt) as a treatment option. The inclusion criteria include completing a previous qualifying trial with telbivudine, while the exclusion criteria include being pregnant or breastfeeding and being co-infected with hepatitis C, hepatitis D, or HIV.",
    "This sample is a phase 3 trial for the treatment of sleep initiation and maintenance disorders and sleep disorders using the drugs zolpidem mr and zolpidem, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for HIV-infected adults who are ART-experienced and have resistance to multiple antiretroviral agents. The study aims to evaluate the efficacy of the drugs GSK1349572 and raltegravir in comparison to their placebos in treating HIV-1 infection.",
    "This sample is a phase 3 trial testing the effectiveness of ee20/drsp (bay86-5300) and ee20/drsp (yaz, bay86-5300) in oral contraception for healthy women between 18 and 45, with specific exclusion criteria related to the use of other steroidal oral contraceptives or drugs that could alter oral contraception metabolism.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the efficacy of ly2189265 and various other drugs in combination therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of duloxetine hydrochloride and placebo in treating patients with generalized anxiety disorder (GAD) without major depressive disorder (MDD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infection, testing the effectiveness of truvada/raltegravir as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drug paliperidone, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs qva149, nva237, qab149, and placebo. The inclusion criteria include age, smoking history, and specific COPD diagnosis, while the exclusion criteria include recent respiratory tract infection, concomitant pulmonary disease, and certain cardiovascular co-morbid conditions.",
    "This sample is a phase 3 clinical trial for patients diagnosed with schizophrenia, testing the drug paliperidone er. The inclusion criteria include specific PANSS scores, no previous antipsychotic use, and being in good health. The exclusion criteria include unstable medical conditions, high risk for adverse events, and substance dependence.",
    "This sample is a phase 3 trial for patients with atrial fibrillation and vascular risk, testing the drug clopidogrel (sr25990c) to reduce the risk of vascular events in patients with high risk criteria, while excluding patients with certain conditions or requirements.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of Aricept (donepezil) in patients aged 45 to 90 years, with specific inclusion and exclusion criteria for patients and caregivers.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin, an antidiabetic drug, in improving glycemic control in renally impaired patients with inadequate control on their current antidiabetic therapy.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer, testing the effectiveness of capecitabine, fluorouracil, and oxaliplatin in combination with surgery for curative resection of the tumor. The eligibility criteria include specific age, performance status, tumor characteristics, and various medical conditions that may exclude patients from participating in the study.",
    "This phase 3 trial is testing the effectiveness of nva237, tiotropium, and salbutamol/albuterol in treating patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are symptomatic and have a smoking history of at least 10 pack years.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of saredutant, escitalopram, and placebo as potential treatments, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of tacrolimus, methotrexate, and sirolimus in treating acute myelocytic leukemia, acute lymphocytic leukemia, chronic myeloid leukemia, and myelodysplastic syndromes in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of quetiapine sr and escitalopram as drugs, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial is testing the effectiveness of vincristine sulfate, cyclophosphamide, and topotecan hydrochloride in treating various types of rhabdomyosarcoma and other soft tissue sarcomas in both adults and children, with specific eligibility criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with orthostatic hypotension and Parkinson's disease, testing the effectiveness of droxidopa in improving symptoms, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the drugs ly2605541 and insulin glargine, with eligibility criteria including having diabetes for at least 1 year, receiving basal insulin and oral antihyperglycemic medications, and having a hemoglobin A1c less than or equal to 9.0%.",
    "This sample is a phase 2/phase 3 trial for the treatment of schizophrenia, focusing on the cognitive effects on schizophrenic patients. The trial will test the drugs cyp-1020 and risperidone, and the eligibility criteria include specific age range, duration of symptoms, severity of symptoms, and previous response to antipsychotic treatment.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate compared to a placebo, with specific inclusion and exclusion criteria based on laboratory results.",
    "This sample is a phase 3 trial for the drug mitiglinide in patients with type 2 diabetes, testing its effectiveness in controlling blood sugar levels. The trial includes patients with stable metformin usage and excludes those with severe diabetic complications or chronic insulin use.",
    "This sample is a phase 3 clinical trial for patients with head and neck neoplasms, testing the effectiveness of pemetrexed, cisplatin, and placebo drugs, with specific inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 3 trial for restless legs syndrome (RLS) patients currently being treated with ropinirole IR, testing the efficacy of different doses and formulations of ropinirole (IR and CR) compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with myocardial infraction, testing the effectiveness of clopidogrel (iscover/plavix) in reducing the risk of thrombolytic therapy, bleeding, and other complications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of anal cancer using cisplatin and fluorouracil drugs, with eligibility criteria including nonmetastatic anal cancer, specific tumor characteristics, age under 80, certain blood counts, and no prior surgery or malignancy within 5 years.",
    "This sample is a phase 3 clinical trial for the treatment of rhinoconjunctivitis, rhinitis, conjunctivitis, and allergy, using drugs such as loratadine, olopatadine, mometasone, prednisone, albuterol sulfate, fluticasone propionate, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic hepatitis B and evidence of cirrhosis, testing the effectiveness of ldt (telbivudine) and lamivudine as potential drugs for treatment.",
    "This phase 3 trial is testing the effectiveness of safinamide and placebo in treating Parkinson's disease, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the treatment of acromegaly using lanreotide (autogel formulation) for 24-56 weeks, with eligibility criteria including a documented diagnosis of active acromegaly and stable treatment with Octreotide LAR for at least 6 months prior to study entry.",
    "This sample is a phase 3 trial for epilepsy patients, testing the drug pregabalin, with inclusion criteria of completed previous protocol and diagnosis of epilepsy with partial seizures, and exclusion criteria of early withdrawal from previous protocol or primary generalized epilepsy.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the drugs docetaxel and vandetanib, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with plaque-type psoriasis, testing the effectiveness of drugs such as cnto 1275 and etanercept, with specific inclusion and exclusion criteria for eligibility.",
    "In this phase 3 trial, the drug montelukast sodium and a placebo are being tested on individuals with acute asthma, with exclusion criteria including women of childbearing age and a history of Chronic Obstructive Pulmonary Disease (COPD).",
    "This sample is a phase 3 trial for patients with major depressive disorder (MDD) who have had an inadequate response to one antidepressant. The study will test the effectiveness of the drug tc-5214 compared to a placebo in treating MDD.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the drug mitiglinide to improve blood glucose control in patients who are not responding to diet and exercise therapy.",
    "This sample is a phase 3 trial for patients with hematologic malignancies at intermediate or high risk of tumor lysis syndrome (TLS), testing the effectiveness of febuxostat and allopurinol as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for dry eye disease, testing the effectiveness of lifitegrast and placebo drugs, with inclusion and exclusion criteria specified.",
    "This sample is a phase 3 clinical trial for patients with gastric carcinoma, testing the efficacy of lapatinib and paclitaxel drugs in two different parts of the study, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for advanced non-small cell lung cancer, testing the effectiveness of erlotinib, cisplatin, and gemcitabine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of moderate to severe plaque psoriasis using clobetasol propionate spray 0.05% and calcitriol ointment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with optic neuritis and multiple sclerosis, testing the effectiveness of simvastatin and placebo in treating acute optic neuritis. The inclusion criteria include abnormal contrast sensitivity score, symptom duration of maximum 4 weeks, and age between 18 and 59 years old. The exclusion criteria include previous optic neuritis in the same eye, pregnancy, nursing, recent steroid or immune-suppressor treatment, liver disease, kidney failure, myopathy, hyperthyroidism, diabetes mellitus, alcoholism, fibrates intake, statin treatment for other diseases, and simultaneous participation in other studies.",
    "This sample is a phase 3 trial for patients with severe hypertension, testing the effectiveness of valsartan plus hydrochlorothiazide as a treatment option. The inclusion criteria include a diagnosis of severe hypertension, while the exclusion criteria include conditions such as heart failure, stroke, and diabetes with poor glucose control.",
    "This sample is a phase 3 clinical trial for patients with cardiovascular disease, testing the efficacy of eptifibatide and placebo in treating patients with stable or unstable angina pectoris, with specific angiographic criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for rheumatoid arthritis patients who have had an inadequate response or intolerance to anti-TNF alpha therapy, and it will test the effectiveness of mabthera/rituxan and methotrexate in reducing symptoms.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis, testing the effectiveness of beclomethasone dipropionate hydrofluoroalkane hfa nasal aerosol compared to a placebo nasal aerosol, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with advanced stage non-small-cell lung carcinoma (NSCLC) of squamous histology, testing the efficacy of afatinib and erlotinib as second-line therapy after platinum-based doublet chemotherapy. The eligibility criteria include measurable disease, adequate performance status, availability of tumor tissue for correlative studies, and written informed consent. Exclusion criteria include prior treatment with EGFR-directed small molecules or antibodies, active brain metastases, and known pre-existing interstitial lung disease.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients, testing the effectiveness of gemcitabine and carboplatin as chemotherapy drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the effectiveness of qva149, tiotropium, and salbutamol/albuterol in patients with moderate to severe chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with depressive disorder, testing the efficacy of bupropion hydrochloride sustained release compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with advanced idiopathic Parkinson's disease, testing the effectiveness of ropinirole prolonged release and ropinirole immediate release in controlling symptoms not adequately controlled with L-dopa.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia and dyslipidemia, testing the effectiveness of pitavastatin, a drug used to lower cholesterol levels, in patients who have completed 12 weeks of treatment in previous studies and have been following a fat and cholesterol restrictive diet.",
    "This sample is a phase 3 clinical trial for the treatment of migraine disorders using sumatriptan succinate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with kidney diseases, specifically those who have undergone renal transplantation. The trial aims to evaluate the effectiveness of methylprednisolone, a steroid, in combination with other immunosuppressive drugs. The inclusion and exclusion criteria outline the specific patient characteristics required for participation in the study.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of ipragliflozin, placebo, and pioglitazone in combination with pioglitazone mono-therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for breast cancer patients with distant metastases or inoperable locally advanced disease, testing the efficacy of capecitabine and hormonal treatment (tamoxifen, exemestane, anastrozole or letrozole) as second-line therapy after progression on first-line hormonal therapy.",
    "This phase 3 trial is testing the effectiveness of golimumab, a drug used to treat ankylosing spondylitis, compared to a placebo, in patients who have been diagnosed with definite ankylosing spondylitis for at least 3 months and have active disease symptoms.",
    "This sample is a phase 3 clinical trial for postmenopausal symptoms, testing the effectiveness of brisdelle (paroxetine mesylate) and placebo capsules in reducing hot flashes in women over 40 years old, who have experienced a certain number of hot flashes per day or per week for a specific duration.",
    "This sample is a phase 3 clinical trial for patients with multiple sclerosis, testing the effectiveness of fingolimod and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as indacaterol and salmeterol, along with placebos, in improving lung function. The study has specific inclusion and exclusion criteria, including age, smoking history, lung function measurements, and the absence of certain medical conditions.",
    "This sample is a phase 3 trial for patients with atrial fibrillation, testing the drugs indobufen and aspirin, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of propiverine hydrochloride er and ir in treating neurogenic urinary bladder disorder, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for idiopathic pulmonary fibrosis, testing the effectiveness of pirfenidone and placebo drugs on patients who meet specific eligibility criteria, including age range, lung function, oxygen saturation, and exclusion criteria such as other medical conditions, substance abuse, and withdrawal from other IPF trials.",
    "This phase 3 trial aims to evaluate the efficacy of darunavir/ritonavir and raltegravir combination therapy, as well as darunavir/r and tenofovir/emtricitabine combination therapy, in treating HIV infections in patients who have not received any previous antiretroviral drugs and have a CD4 cell count of \u2264 500/mm3.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drug rosiglitazone (brl49653c), and the inclusion criteria require patients to be managed by SU and have adequate blood, liver, and kidney function, while exclusion criteria include serious cardiovascular or hepatic disease.",
    "This phase 3 clinical trial aims to evaluate the efficacy of Sativex and placebo in treating central neuropathic pain caused by multiple sclerosis, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial is testing the effectiveness of cephalexin and ciprofloxacin in treating bladder cancer patients with specific disease characteristics and patient characteristics, while also considering prior concurrent therapy.",
    "This phase 3 trial aims to evaluate the effectiveness of citalopram hydrobromide in reducing bothersome hot flashes in postmenopausal women with a history of breast cancer or those who refused estrogen replacement therapy due to perceived increased risk of breast cancer.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drugs bi 1356 and voglibose, with eligibility criteria including stable antidiabetic therapy, specific HbA1c levels, age range, and BMI limit.",
    "This sample is a phase 3 trial testing the drug asenapine for elderly subjects with psychosis, with specific inclusion and exclusion criteria related to medical conditions and dementia.",
    "This sample is a phase 2/phase 3 trial for adult patients with acute myelogenous leukemia (AML) and unfavorable risk cytogenetics, testing the drug decitabine. The inclusion criteria include patients in first or subsequent complete response (CR) or complete remission without full platelet recovery (CRp), with a performance status of 0, 1, or 2, and adequate organ function. The exclusion criteria include pregnancy or lactation, HIV positivity, active and uncontrolled disease/infection, inability or unwillingness to sign the consent form, and no other investigational therapy within the past 14 days.",
    "This sample is a phase 3 clinical trial for patients with soft tissue sarcoma, testing the efficacy of ombrabulin (ave8062) compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with cancer, specifically breast cancer, testing the effectiveness of the drugs ixabepilone + capecitabine and capecitabine in patients who have received prior treatment with anthracycline and taxane, have not had more than two prior chemotherapy regimens, have not had brain and/or leptomeningeal metastases, and do not have Grade 2 or worse neuropathy.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide and taspoglutide drugs in combination with metformin and/or pioglitazone or rosiglitazone, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial testing the efficacy of a fixed-dose combination of telmisartan and amlodipine in patients with essential hypertension, with various exclusion criteria and eligibility requirements.",
    "This sample is a phase 3 trial for the drug aripiprazole in the treatment of autistic disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the effectiveness of teriflunomide and placebo in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of ly2605541, insulin glargine, and insulin lispro in combination with a multiple daily injection regimen. The eligibility criteria include having diabetes for at least 1 year, specific HbA1c and BMI values, and using a reliable method of birth control for women of childbearing potential. Exclusion criteria include certain medications, medical conditions, and recent hospitalizations related to glucose control.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the efficacy and tolerability of Seroquel SR as an antipsychotic treatment, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of insulin degludec and insulin glargine in combination with oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for Parkinson's disease, testing the drug istradefylline (kw-6002), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for gastroesophageal reflux disease, testing the effectiveness of dexlansoprazole mr and placebo in reducing heartburn symptoms, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of ipragliflozin, metformin, and placebo in combination with metformin mono-therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for sepsis, testing the drugs metoclopramide, zinc, and selenium, with eligibility criteria including age, time of admission, and the presence of specific medical devices.",
    "This sample is a phase 3 trial for the treatment of acromegaly using lanreotide autogel 120 mg, with specific inclusion and exclusion criteria, including pituitary adenoma size, visual field defects, and history of hypersensitivity to lanreotide or similar drugs.",
    "This sample is a phase 3 clinical trial for the drug laquinimod in patients with multiple sclerosis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with hepatocellular carcinoma (HCC) testing the effectiveness of sorafenib (Nexavar, Bay43-9006) compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with brain edema or brain tumor, testing the drugs hcrf and placebo hcrf, with eligibility criteria including confirmed diagnosis, symptomatic peritumoral brain edema, stable dexamethasone dose, and capability for self-administration of injections.",
    "This sample is a phase 3 clinical trial for female patients with HER2-negative breast cancer who have experienced disease progression after first-line treatment with Avastin and chemotherapy. The study aims to evaluate the efficacy of bevacizumab (Avastin) in combination with chemotherapy as a second-line treatment option.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of paroxetine and lithium as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for diabetic macular edema, testing the drugs ranibizumab and sham to ranibizumab, with inclusion criteria including visual acuity impairment and stable diabetes medication for the last 3 months.",
    "This sample is a phase 3 clinical trial for pancreatic cancer, testing the efficacy of gemcitabine plus ts-1 and ts-1 alone as treatment options, with specific eligibility criteria for patients to be enrolled in the study.",
    "This sample is a phase 3 trial for psoriasis, testing the drug etanercept, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus (HCV) using drugs such as asunaprevir, daclatasvir, pegylated-interferon alfa 2a, and ribavirin, with specific eligibility criteria for participants.",
    "This phase 3 trial aims to evaluate the effectiveness of desvenlafaxine succinate sustained-release (dvs sr) and escitalopram in postmenopausal women aged 40-70 with major depressive disorder (MDD), as determined by the Montgomery-Asberg Depression Rating Scale (MADRS) score, while excluding those with certain medical conditions and recent substance abuse.",
    "This sample is a phase 3 clinical trial for patients diagnosed with schizophrenia or schizoaffective disorder, testing the effectiveness of olanzapine, amantadine, metformin, and zonisamide as potential treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe atopic dermatitis, testing the effectiveness of tacrolimus ointment as a treatment option.",
    "This sample is a phase 3 clinical trial for patients with unresectable, locally advanced or metastatic hereditary or sporadic Medullary Thyroid Cancer, testing the drug zd6474 (vandetanib) as a potential treatment option. The inclusion criteria include a confirmed diagnosis of the disease, presence of measurable tumor, and ability to swallow medication, while the exclusion criteria include recent major surgery or chemotherapy, recent radiation therapy (except palliative radiotherapy), brain metastases or spinal cord compression (unless treated and stable), significant cardiac events, and previous treatment with ZD6474.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma and plasma cell neoplasm, testing the drugs prednisone and thalidomide in combination with autologous stem cell transplantation. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 trial for the treatment of sleep initiation and maintenance disorders, using drugs such as zolpidem-mr, zolpidem, and placebo, with inclusion criteria based on the DSM-IV criteria for primary insomnia diagnosis.",
    "This sample is a phase 3 clinical trial for patients with recurrent ovarian cancer who have received prior chemotherapy with cisplatin or carboplatin. The study aims to evaluate the efficacy of carboplatin and cisplatin in treating the disease.",
    "This sample is a phase 3 trial for colorectal cancer patients, testing the drugs cetuximab and folfox, with inclusion criteria including being part of the PETACC08 study and having an available FFPE tumor sample for miR-31-3p and miR-31-5p expression testing.",
    "This sample is a phase 3 clinical trial for the treatment of chronic pain using oxymorphone extended release, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2/phase 3 trial that aims to evaluate the effectiveness of aspirin, clopidogrel, and simvastatin in patients with transient ischemic attack (TIA) or stroke, who are not eligible for acute thrombolysis or other acute interventions. The eligibility criteria include age 40 or older, specific neurological deficits, and a time window for randomization within 24 hours of symptom onset. The exclusion criteria include certain types of symptoms, contraindications for trial medication, and participation in other clinical trials.",
    "This sample is a phase 3 trial for patients with reflux esophagitis, testing the effectiveness of esomeprazole and omeprazole, two drugs used to treat the condition, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with myocardial infraction, testing the effectiveness of bivalirudin and unfractionated heparin as drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with chronic kidney disease stage 5, testing the drugs fosrenol (lanthanum carbonate) and sevelamer hydrochloride, with inclusion criteria of adults receiving dialysis and exclusion criteria including gastrointestinal disorders, pregnancy or nursing, current use of lanthanum carbonate or sevelamer hydrochloride, HIV positivity, and significant liver disease.",
    "This sample is a phase 3 clinical trial for the treatment of depression in patients with bipolar I disorder, testing the efficacy of armodafinil compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with idiopathic Parkinson's disease, testing the effectiveness of ropinirole, a dopamine agonist, in improving symptoms and control of the disease.",
    "This phase 3 clinical trial aims to evaluate the efficacy of oxycodone naloxone and oxycodone pr tablets in managing cancer pain or non-cancer pain, specifically chronic low back pain and osteoarthritis, in patients currently receiving a WHO step II or III opioid. The study also focuses on patients with opioid-related constipation and includes eligibility criteria such as age, negative pregnancy test, and ability to comply with the study protocol. Exclusion criteria include contraindications to the study medications, significant impairment of cardiovascular, respiratory, liver or kidney function, and history of alcohol or drug abuse.",
    "This sample is a phase 3 clinical trial for painful diabetic peripheral neuropathy, testing the effectiveness of pregabalin and placebo in patients with type 1 or 2 diabetes who are currently treated with one NSAID for co-morbid pain.",
    "This sample is a phase 3 clinical trial for early rheumatoid arthritis, testing the effectiveness of methotrexate and a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of vildagliptin and placebo as oral anti-diabetic therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with bipolar disorder or mania, testing the effectiveness of cariprazine and placebo in treating the disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis B, testing the effectiveness of telbivudine and peginterferon alpha-2a in reducing viral load and liver inflammation, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is testing the effectiveness of azilsartan medoxomil and amlodipine, a combination of angiotensin II receptor blockers and calcium channel blockers, in treating essential hypertension with specific blood pressure criteria, while excluding patients with certain medical conditions or taking certain medications.",
    "This sample is a phase 3 clinical trial for hypertension, testing the drugs placebo, valsartan, and fimasartan, with inclusion criteria including subjects aged 20 to 75 years with essential hypertension and exclusion criteria including severe hypertension and patients with secondary hypertension.",
    "This sample is a phase 3 clinical trial for the treatment of idiopathic restless legs syndrome, using the drug spm 962 and a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the treatment of rheumatoid arthritis using the drug fostamatinib, along with methotrexate, and placebo. The eligibility criteria include specific symptoms, blood test results, and a history of positive rheumatoid factor or radiographic erosion.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the drugs saxagliptin and placebo, with inclusion criteria including a diagnosis of type 2 diabetes, a history of low CrCl, and HbA1c levels between 7.0% and 11.0%, and exclusion criteria including type 1 diabetes, previous or current treatment with DPP-IV inhibitors and/or GLP-1 mimetics.",
    "This phase 3 trial is testing the efficacy of oral treprostinil sustained release tablets compared to placebo in patients with pulmonary hypertension, who are currently receiving approved endothelin receptor antagonists and/or phosphodiesterase-5 inhibitors, and meet specific inclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic or unresectable colorectal cancer, testing the efficacy of fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin as second-line chemotherapy after progression on first-line treatment, with specific eligibility criteria for patients and exclusion criteria for concurrent conditions.",
    "This phase 3 trial is investigating the effectiveness of indacaterol, formoterol, and placebos in treating chronic obstructive pulmonary disease (COPD) in adults aged 40 and above, with specific inclusion and exclusion criteria outlined in the study.",
    "This sample is a phase 3 trial for prostate cancer, testing the drugs degarelix and goserelin acetate, with inclusion criteria requiring written consent and completion of the CS35 trial, and exclusion criteria including withdrawal from the CS35 trial and having had the end of trial visit in CS35 prior to approval of the CS35A protocol.",
    "This sample is a phase 2/phase 3 trial for glaucoma patients requiring first-time filtering surgery, testing the drugs ranibizumab and mitomycin (mmc), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the drug brivaracetam in patients with well-characterized focal epilepsy or epileptic syndrome, who have at least 2 but not exceeding 40 partial onset seizures per 4 weeks. The study includes subjects aged 16 to 75 years who are on a stable dose of 1 or 2 concomitant Antiepileptic Drugs (AEDs).",
    "This sample is a phase 3 clinical trial that aims to evaluate the effectiveness of casopitant and other drugs in reducing chemotherapy-induced nausea and vomiting in patients with solid malignant tumors receiving anthracycline and cyclophosphamide-containing moderately emetogenic chemotherapy regimens.",
    "This sample is a phase 3 trial for smoking cessation, testing the effectiveness of placebo and varenicline drugs on participants with stable cardiovascular disease and smoking more than 10 cigarettes per day.",
    "This sample is a phase 3 clinical trial for ovarian cancer, testing the drugs trabectedin, doxil, and dexamethasone, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial testing the effectiveness of Sativex, a cannabis-based medication, compared to a placebo in treating peripheral neuropathy pain in patients who have not found relief with current therapy.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of candesartan cilexetil, a blood pressure medication, in reducing diabetic retinopathy.",
    "This sample is a phase 3 trial for pediatric patients with chronic hepatitis B virus, testing the efficacy of entecavir compared to placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of schizophrenia, testing the drugs ziprasidone and risperidone, with inclusion criteria of a diagnosis of schizophrenia and a CGI-S score of 4 or less at baseline, and exclusion criteria including concurrent antipsychotic treatment and recent treatment with antidepressants or mood stabilizers.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic colorectal cancer, testing the effectiveness of mitomycin c, capecitabine, and bevacizumab as a combination therapy. The eligibility criteria include having a histological diagnosis of colorectal cancer, metastatic disease that is not resectable, age over 18 years, and adequate bone marrow and hepatic function. Exclusion criteria include uncontrolled hypertension, active bleeding disorders, and CNS metastases.",
    "This sample is a phase 3 clinical trial for asthma, testing the effectiveness of various inhalation powders (fluticasone furoate/vilanterol, fluticasone furoate, and fluticasone propionate) in patients aged 12 and above, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide and placebo in combination with metformin or sulfonylurea therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the drug rotigotine in patients with early and advanced idiopathic Parkinson's disease who have early morning motor impairment, with exclusion criteria for atypical Parkinsonian syndromes.",
    "This phase 3 clinical trial is testing lenalidomide and melphalan as a treatment for multiple myeloma patients who have stable or responsive disease, with specific eligibility criteria including prior therapy limitations and various medical conditions.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of Seroquel (quetiapine) in stable schizophrenic patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of olodaterol and tiotropium inhalers compared to placebos, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of primary insomnia using the drug suvorexant and a dose-matched placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer, testing the effectiveness of docetaxel, 5-fluorouracil, doxorubicin, and cyclophosphamide as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for children aged 12-24 months with symptoms of atopic dermatitis. The study aims to evaluate the effectiveness of levocetirizine and placebo in treating atopic dermatitis, with inclusion criteria including a SCORAD Index >= 10 and a family history of atopy. Exclusion criteria include the use of certain medications and the presence of other dermatological conditions that may interfere with the evaluation of the response to treatment.",
    "This sample is a phase 3 clinical trial for patients with stage IV melanoma, testing the effectiveness of temozolomide and dacarbazine as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using atomoxetine hydrochloride and placebo as drugs, with specific inclusion and exclusion criteria for patients.",
    "This phase 3 trial is investigating the effectiveness of irbesartan, an angiotensin receptor blocking agent, compared to placebo in patients with atrial fibrillation and cardiovascular disease, who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with acute coronary syndromes, testing the efficacy of prasugrel and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of metastatic adenocarcinoma of the pancreas, using the drugs amg 479 and gemcitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for children and adolescents with familial hypercholesterolemia, testing the effectiveness of rosuvastatin and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for chronic primary insomnia, testing the effectiveness of esmirtazapine and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of sm-13496 (lurasidone hcl), risperidone, and placebo as potential drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of type 2 diabetes mellitus, testing the drugs ta-7284 low, ta-7284 high, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the effectiveness of paliperidone er tablets, quetiapine tablets, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for kidney transplant patients, testing the drug sirolimus, with inclusion criteria including dialysis patients receiving their first kidney transplant and a weight over 88 pounds, and exclusion criteria including very high cholesterol levels, obesity, and organ donors over a certain age.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) patients who have completed a screening protocol, and it involves the use of oros methylphenidate hcl, Ritalin, and placebo as treatment options. The inclusion criteria include previous use of methylphenidate, agreement to take the study drug, and compliance with the study visit schedule. The exclusion criteria include gastrointestinal problems, glaucoma, seizure disorder, depression, allergy to methylphenidate, high blood pressure, and menstruation in females.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of different drugs such as fluticasone furoate/ vilanterol and fluticasone furoate, with specific eligibility criteria including age, lung function, and previous medication use.",
    "This phase 3 trial aims to evaluate the effectiveness of dapagliflozin, a drug used to treat type 2 diabetes mellitus, in patients with inadequate glycaemic control and comorbid cardiovascular disease. The study includes patients who have been on uninterrupted anti-diabetic treatment for at least 8 weeks and excludes those with type 1 diabetes, poorly controlled diabetes, or any clinically significant illness that may compromise their safety or study participation.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of liraglutide compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of linagliptin and placebo in combination with metformin and a sulphonylurea drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for HIV infections, testing the drug tipranavir. The eligibility criteria include having completed a previous tipranavir/ritonavir trial, adherence to dosing protocol and visit requirements, and acceptable baseline organ function. Exclusion criteria include pregnancy, substance abuse, medical conditions that interfere with participation, and hypersensitivity to tipranavir or ritonavir.",
    "This phase 3 trial is investigating the use of pregabalin in patients with peripheral neuropathy and HIV infections, with specific inclusion and exclusion criteria related to a previous trial (A0081066).",
    "This sample is a phase 3 trial for women with menorrhagia (heavy menstrual bleeding) using tranexamic acid tablets (xp12b) as a potential treatment, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of ziprasidone, a drug used to treat bipolar disorder, compared to a placebo, in patients with a primary diagnosis of Bipolar I Disorder.",
    "This sample is a phase 3 clinical trial for patients aged 45 and older with established vascular disease and atherogenic dyslipidemia, testing the effectiveness of extended release niacin and simvastatin in reducing LDL-C and increasing HDL-C levels.",
    "This sample is a phase 2/phase 3 trial for patients with gastroesophageal reflux disease (GERD), testing the effectiveness of rabeprazole and low dose tricyclic antidepressant in reducing GERD symptoms in patients currently being treated with a PPI but still experiencing symptoms at least 2 times per week.",
    "This sample is a phase 3 clinical trial for patients with locally advanced colorectal cancer who have undergone complete resection of the primary tumor and received neoadjuvant fluoropyrimidine-based chemoradiotherapy. The study aims to evaluate the efficacy and safety of capecitabine and oxaliplatin as treatment options.",
    "This sample is a phase 3 clinical trial for previously untreated follicular stage III or IV non-Hodgkin's lymphoma, testing the effectiveness of cyclophosphamide, prednisone, and vincristine sulfate as treatment options, with specific eligibility criteria for patients.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of rimonabant and placebo drugs in reducing HbA1C levels, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of fluticasone cream compared to a placebo in treating mild to moderate acute flare of atopic dermatitis in children aged 2 to 10 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with mediastinal cancer, metastatic cancer, and testicular germ cell tumor, testing the effectiveness of cisplatin, etoposide, and ifosfamide as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the drug vildagliptin, and the eligibility criteria include inadequate control with current medications and a specific range of HbA1c levels.",
    "This sample is a phase 3 trial for allergic rhinoconjunctivitis, testing the drugs depiquick birch and placebo, with specific inclusion and exclusion criteria related to allergic symptoms, sensitization to tree allergens, and asthma.",
    "This phase 3 trial is investigating the effectiveness of quetiapine fumarate xr and placebo in treating Generalized Anxiety Disorder, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the drug goserelin to preserve ovarian function during neoadjuvant and/or adjuvant chemotherapy, with specific eligibility criteria including age, cancer stage, hormone-receptor status, and performance score.",
    "This sample is a phase 3 clinical trial for insomnia, testing the effectiveness of the drug vec-162 (in various doses) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic castration-resistant prostate cancer, testing the efficacy of abiraterone acetate and prednisone/prednisolone compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of drugs such as ezetimibe and atorvastatin, as well as a placebo, in lowering LDL levels. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 trial for primary insomnia, where the drugs being tested are almorexant, placebo, and zolpidem, and the eligibility criteria include being an adult with a diagnosis of primary insomnia and not having any other sleep disorders or mental disorders.",
    "This sample is a phase 2/phase 3 trial for hepatocellular carcinoma, testing the drugs menatetrenone and placebo, with eligibility criteria including age, performance status, diagnosis confirmation, liver function, and exclusion criteria such as extrahepatic metastasis and previous treatments for hepatocellular carcinoma or hepatitis.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis using the drugs apremilast and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial aims to evaluate the effectiveness of cl-108 (hydrodocone 7.5 mg, acetaminophen 325 mg, promethazine 12.5 mg) compared to a placebo in reducing post-operative pain in patients who have undergone surgical extraction of impacted third molar teeth and are likely or possibly nausea-prone.",
    "This sample is a phase 3 trial for the treatment of major depressive disorder using duloxetine hydrochloride and placebo drugs, with specific inclusion and exclusion criteria related to the patient's medical history and comorbidities.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium and olodaterol in improving lung function, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of buprenorphine compared to placebo in reducing moderate to severe chronic low back pain in patients currently taking \u226460 mg oral morphine/day or equianalgesic dose of another opioid for 1 week or longer.",
    "This sample is a phase 2/phase 3 trial for early Parkinson's disease, testing the drugs SPM 962 and placebo, with inclusion criteria including a diagnosis of Parkinson's disease, age between 30 and 80, Hoehn & Yahr stage 1-3, and a total UPDRS Part 2 and 3 score over 10, and exclusion criteria including previous participation in a trial with SPM 962, L-dopa treatment for over 6 months, psychiatric symptoms, orthostatic hypotension, history of epilepsy or serious cardiac disorder/arrhythmia, and various other criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of saxagliptin and placebo in combination with metformin for glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and an acute exacerbation. The study will test the effectiveness of budesonide/formoterol and prednisolone in treating acute symptoms of COPD, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with drug-resistant epilepsy, specifically targeting those with cluster seizures, and the drug being tested is levetiracetam. The inclusion criteria include age, duration of epilepsy, and previous treatment history, while the exclusion criteria include certain medical conditions and medication usage.",
    "This sample is a phase 3 trial for HIV-infected individuals with specific eligibility criteria, including prior antiretroviral experience and resistance to certain drug classes, and exclusion criteria such as acute laboratory abnormalities and history of pancreatitis or hepatitis. The study aims to test the drug gw873140 and requires participants to receive a ritonavir-boosted protease inhibitor during treatment studies.",
    "This sample is a phase 3 clinical trial for chronic plaque psoriasis, testing the drugs placebo, secukinumab (ain457), and etanercept, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of various drugs including gsk573719/gw642444 and gsk573719 in improving lung function and reducing symptoms. The eligibility criteria include age, gender, smoking history, disease severity, and other exclusion criteria such as pregnancy, asthma, and other respiratory disorders.",
    "This phase 3 trial aims to investigate the effects of folic acid, vitamin B12, and vitamin B6 supplementation compared to a placebo on patients with coronary artery disease, myocardial infraction, and cerebrovascular stroke, who have undergone coronary angiography, with inclusion and exclusion criteria specified.",
    "This phase 3 trial focuses on patients with venous thromboembolism, including those with factor V Leiden, who have completed anticoagulation therapy within the last two years and are not currently on anticoagulation therapy. The drug being tested is warfarin.",
    "This phase 3 clinical trial is testing the effectiveness of gemcitabine hydrochloride in treating various stages of pancreatic cancer, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer that has spread to the bone, testing the effectiveness of docetaxel, zd4054, and placebo drugs in combination with surgical or medical castration treatment.",
    "This phase 3 trial is testing the drug ngx-4010 for the treatment of postherpetic neuralgia (PHN), a type of chronic pain that occurs after shingles, and the eligibility criteria include having a diagnosis of PHN, intact skin over the painful area, and being on a stable regimen of chronic pain medications.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C who have not responded to previous therapy with PEGinterferon alpha plus ribavirin. The study aims to evaluate the efficacy of ribavirin and placebo in combination with other eligibility criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate, glimepiride, and placebos, while excluding patients with certain medical conditions and previous use of specific medications.",
    "This sample is a phase 3 trial for the treatment of b-cell lymphoma using drugs such as bevacizumab, rituximab, chop, and placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for allergic rhinitis, testing the effectiveness of bdp nasal aerosol and placebo in children aged 4 to 11 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of benign prostatic hyperplasia using the drugs tadalafil and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial is focused on patients with locally advanced adenocarcinoma of the prostate, and it aims to evaluate the effectiveness of multiple drugs including bicalutamide, buserelin, flutamide, goserelin, leuprolide acetate, and nilutamide in combination with wide-field pelvic irradiation. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for cystic fibrosis patients, testing the effectiveness of mannitol and placebo drugs on lung function, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of quetiapine fumarate as a treatment option. The inclusion criteria include patients with a clinical diagnosis of schizophrenia who are able to provide informed consent and comply with the study requirements. Exclusion criteria include patients with a history of non-compliance, lack of response to previous quetiapine treatment, recent participation in another drug study, or previous participation in this specific study.",
    "This phase 3 trial is testing the drugs exemestane, tamoxifen, and triptorelin in patients with histologically confirmed breast cancer that has been completely resected, with eligibility criteria including hormone receptor positivity and no distant metastases.",
    "This sample is a phase 3 clinical trial for the treatment of prostate cancer using leuprorelin acetate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of bacterial pneumonia, testing the effectiveness of ceftaroline fosamil for injection, iv ceftriaxone, placebo, and clarithromycin, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) who have failed one or two prior chemotherapy regimens. The study will test the effectiveness of vandetanib and erlotinib as potential treatments for NSCLC.",
    "This sample is a phase 3 clinical trial for patients with refractory epilepsy and seizures, testing the effectiveness of the drug retigabine compared to a placebo, with specific inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 2/phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as indacaterol, formoterol, and tiotropium, as well as placebos, in improving lung function. The study has specific inclusion and exclusion criteria, including age, smoking history, lung function measurements, and the absence of certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with previously untreated diffuse large B-cell lymphoma or follicular non-Hodgkin lymphoma, testing the efficacy of rituximab in combination with CHOP or CVP chemotherapy regimens, with specific eligibility criteria and exclusion criteria related to cardiovascular disease and adverse events.",
    "This sample is a phase 3 trial for patients diagnosed with acute coronary disease, testing the effectiveness of clopidogrel and acetylsalicyclic acid (ASA) in reducing the risk of bleeding and other complications.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of liraglutide, sitagliptin, and metformin in combination with metformin alone, with specific eligibility criteria including HbA1c levels and BMI.",
    "This sample is a phase 3 clinical trial for metastatic colorectal cancer, testing the effectiveness of cediranib, folfox, xelox, and a cediranib placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the effectiveness of enzalutamide and placebo in treating the disease, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with atrial fibrillation, testing the effectiveness of vernakalant injection and amiodarone injection in cardioversion, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with metastatic or locally-advanced pancreatic adenocarcinoma, testing the drugs ag-013736, gemcitabine, and placebo, with inclusion criteria including confirmed diagnosis and adequate organ function, and exclusion criteria including prior chemotherapy treatment and inability to take oral medication.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of saxagliptin and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of overactive bladder, testing the drugs propiverine hydrochloride and tolterodine extended-release tablet, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for patients with uncontrolled hypertension on lisinopril monotherapy, testing the combination of carvedilol and valsartan as a potential treatment option. The inclusion criteria include subjects with a 24-hour ambulatory diastolic blood pressure >85 mmHg, while the exclusion criteria include various medical conditions and contraindications.",
    "This phase 3 trial is testing the effectiveness of budesonide/formoterol (symbicort) and budesonide in treating asthma in children aged 6-15 who have already received treatment with inhaled corticosteroids.",
    "This sample is a phase 3 clinical trial for Parkinson's disease and dyskinesia, testing the drugs sarizotan and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and it is testing the effectiveness of two drugs, umeclidinium/vilanterol and tiotropium, in improving lung function and reducing symptoms. The eligibility criteria include being an outpatient, being 40 years or older, having a history of COPD, and having a certain severity of disease.",
    "This sample is a phase 3 clinical trial for participants with inadequately controlled type 2 diabetes mellitus, testing the effectiveness of a new formulation of insulin glargine (hoe901-u300) and comparing it to lantus (insulin glargine). The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia, testing the effectiveness of cytarabine or supportive care and dacogen (decitabine) in treating the disease, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial aims to evaluate the efficacy of bazedoxifene/conjugate estrogens (ce) and raloxifene compared to placebo in generally healthy, postmenopausal women with endometrial hyperplasia and osteoporosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for glaucoma and ocular hypertension, testing the effectiveness of two different eye drop solutions (duotrav and cosopt) containing different combinations of drugs (travoprost, timolol, dorzolamide) as treatment options, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of oxaliplatin based chemotherapy, panitumumab, irinotecan based chemotherapy, and bevacizumab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for chronic hepatitis C, testing the drugs sof, rbv, placebo to match sof, and placebo to match rbv, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for the treatment of major depressive disorder using the drug vortioxetine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the drug clevudine in patients with hepatitis B, with specific inclusion and exclusion criteria outlined for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with cystic fibrosis and pancreatic exocrine insufficiency, testing the effectiveness of pancrelipase delayed release compared to a placebo comparator, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients undergoing kidney transplantation, testing the drug fty720. The eligibility criteria include age, type of transplantation, and exclusion criteria such as multi-organ transplantation and certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of methotrexate, ocrelizumab, and placebo as treatments, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for asthma, testing the drug levocetirizine, with inclusion criteria requiring completion of a previous 18-month treatment period and no exclusion criteria specified.",
    "This sample is a phase 3 clinical trial for patients with unresectable metastatic colorectal cancer, testing the effectiveness of fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin as chemotherapy drugs, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 trial for patients with chronic heart failure, focusing on the effectiveness of olmesartan medoxomil + candesartan cilexetil placebo and olmesartan medoxomil placebo + candesartan cilexetil drugs in reducing symptoms and improving quality of life. The eligibility criteria include age between 18 and 85 years, recent hospital admission with CHF diagnosis, functional NYHA class II-IV with LVEF < 40%, and blood BNP levels > 400 pg/ml or NT-ProBNP levels > 1500 pg/ml.",
    "This sample is a phase 3 clinical trial for chronic kidney disease patients on hemodialysis, testing the effectiveness of the drugs asp1585 and sevelamer hydrochloride in treating hyperphosphatemia.",
    "This phase 3 trial is testing the effectiveness of metformin, ly2189265, and placebos in treating type 2 diabetes, with specific eligibility criteria including disease duration, HbA1c levels, BMI, and willingness to perform self-monitoring and self-injection.",
    "The sample is a phase 3 clinical trial for fibromyalgia, testing the effectiveness of the drugs placebo and xyrem\u00ae in subjects who meet the American College of Rheumatology diagnostic criteria for fibromyalgia.",
    "This sample is a phase 3 clinical trial testing the effectiveness of valganciclovir, an antiviral drug, in treating patients with Crohn's disease, ulcerative colitis, unclassifiable colitis, or pouchitis who have cytomegalovirus infections. The inclusion criteria include patients needing treatment with corticoids and/or immunosuppressive drugs, and who have had a new attack in the previous three months. Exclusion criteria include serious or complicated attacks, psychiatric diseases, participation in another clinical trial, and other serious diseases."
]
